US-based biopharmaceutical company Biofrontera has finished enrolling subjects in its multicentre Phase III trial of Ameluz ...

The European stock markets were tracking mostly higher in Tuesday trading as The Stoxx Europe 600 rose 0.44%, Germany's DAX increased 0.86%, the FTSE 100 in London was up 0.16%, France's CAC 40 ...

2. Scalable, long-term solution: Kochava has been in the deep linking business since 2011 and is trusted by some of the biggest names in the world of mobile app advertising. We're here for the long ...

Biofrontera announced the enrollment of the final patient in its Phase 3 clinical trial evaluating Ameluz for the treatment of mild to moderate ...

Australia: Researchers have found in a small study that immune checkpoint inhibitors (ICIs) used for cancer treatment ...

Biofrontera (NASDAQ:BFRI – Get Free Report) is projected to release its earnings data before the market opens on Thursday, March 13th. Analysts expect Biofrontera to post earnings of ($0.07) per share ...

Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with ...

Find out more about the technology behind skin-tightening radiofrequency treatment Oligio and why it works for all skin tones ...

Because of its potential association with systemic diseases and malignancies, it is recommended that patients with spiny ...

Q: AN seborrheic keratoses give you back ache? My back is covered in it and I’m getting pain from about where my lungs are up to my shoulders. Seborrheic keratoses are harmless warty spots that ...

What Are Actinic Keratoses? Actinic keratoses (AKs) are a common skin condition characterized by rough, red, scaly patches, crusts, or sores on the top layer of skin (see Figures 1 & 2).

Opens in a new tab or window Use of immune checkpoint inhibitors for cancer was associated with a significant reduction in actinic keratoses in a small study. The effect was greatest in younger ...